Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (131-140 of 297) with videos related to

Pageof 30
Sort By:
The European Respiratory Journal|February 6, 2016
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosisStephanie Shin, Christopher S King, Nitin Puri, et al.
Thorax|December 24, 2021
Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosisNa'ama Avitzur, Elizabeth M Noth, Mubasiru Lamidi, et al.
Chest|August 21, 2021
Lung Transplantation for Patients With COVID-19Christopher S King, Hannah Mannem, Jasleen Kukreja, et al.
Chest|December 15, 2012
The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosisSteven D Nathan, Taylor Reffett, A Whitney Brown, et al.
Chest|August 27, 2013
The influence of alternative instruction on 6-min walk test distanceNargues A Weir, A Whitney Brown, Oksana A Shlobin, et al.
Pulmonary Circulation|April 19, 2021
Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing databaseSteven D Nathan, Scott D Barnett, Christopher S King, et al.
Annals of the American Thoracic Society|July 6, 2023
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE TrialSteven D Nathan, Boris Medarov, Lawrence Ho, et al.
The European Respiratory Journal|May 19, 2018
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumoniaChristopher S King, A Whitney Brown, Oksana A Shlobin, et al.
Respiratory Medicine|June 16, 2010
Categorization and impact of pulmonary hypertension in patients with advanced COPDMichael J Cuttica, Ravi Kalhan, Oksana A Shlobin, et al.
Chest|August 23, 2022
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative ReviewAaron Yarlas, Stephen C Mathai, Steven D Nathan, et al.
Pageof 30

Showing results (131-140 of 297) with videos related to

Sort By:
Pageof 30
The European Respiratory Journal|February 6, 2016
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosisStephanie Shin, Christopher S King, Nitin Puri, et al.
Thorax|December 24, 2021
Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosisNa'ama Avitzur, Elizabeth M Noth, Mubasiru Lamidi, et al.
Chest|August 21, 2021
Lung Transplantation for Patients With COVID-19Christopher S King, Hannah Mannem, Jasleen Kukreja, et al.
Chest|December 15, 2012
The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosisSteven D Nathan, Taylor Reffett, A Whitney Brown, et al.
Chest|August 27, 2013
The influence of alternative instruction on 6-min walk test distanceNargues A Weir, A Whitney Brown, Oksana A Shlobin, et al.
Pulmonary Circulation|April 19, 2021
Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing databaseSteven D Nathan, Scott D Barnett, Christopher S King, et al.
Annals of the American Thoracic Society|July 6, 2023
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE TrialSteven D Nathan, Boris Medarov, Lawrence Ho, et al.
The European Respiratory Journal|May 19, 2018
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumoniaChristopher S King, A Whitney Brown, Oksana A Shlobin, et al.
Respiratory Medicine|June 16, 2010
Categorization and impact of pulmonary hypertension in patients with advanced COPDMichael J Cuttica, Ravi Kalhan, Oksana A Shlobin, et al.
Chest|August 23, 2022
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative ReviewAaron Yarlas, Stephen C Mathai, Steven D Nathan, et al.
Pageof 30